SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending following reports that President Trump declared the conflict with Iran "very complete" and "ahead of schedule," triggering a significant market rally and a sharp reversal in oil prices from recent highs. The community is intensely debating whether these comments are genuine peace signals or a strategic market manipulation, leaving many skeptical about the true resolution of the conflict and the market's future direction.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is surging, fueling a significant short squeeze, after reports of President Trump's optimistic statements suggested the Iran war is 'very complete, pretty much,' leading to a market rebound and a sharp drop in oil prices amid divided investor sentiment.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending after reporting strong quarterly results driven by significant MIPLYFFA revenue, which exceeded expectations and signals a commercial breakthrough, fueling community discussions around future profitability, anticipated European approval, and the impact of a new CFO hire.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is highly volatile amid escalating Middle East tensions threatening global oil supply, while conflicting statements from former President Trump suggesting the conflict is "very complete" are causing sharp, contentious reversals. The market remains deeply divided on whether sustained geopolitical risks will outweigh potential de-escalation and strategic reserve releases.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is gaining attention following a new DOE agreement for its IMSR Fuel Salt production pilot and recent positive analyst coverage with a $15 price target. The community actively discusses its Integral Molten Salt Reactor technology as a "dark horse" in the advanced nuclear sector, comparing its potential to peers like OKLO, especially given its strategic position to meet escalating AI data center energy demands.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as investors weigh its upcoming earnings and potential nuclear awards against a backdrop of increasing demand for AI data center power. This creates a split in community sentiment between long-term bullishness for its advanced nuclear technology and skepticism over its pre-revenue status.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as escalating geopolitical tensions, particularly concerning a potential conflict involving Iran and its impact on rising oil prices, are driving widespread market fear and discussions of increased volatility. The community is actively debating whether to accumulate UVIX as a hedge against a market correction or if these events are already priced into the market amid perceived manipulation.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is seeing an explosive rally and volume spike, driven by a recently announced $40 million private placement. This has ignited speculation of a short squeeze among bulls, though bears are quick to point out the offering's significantly lower per-share price, raising concerns about dilution and sustainability.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is trending following its Q3 earnings, which saw a significant EPS beat alongside a revenue miss, sparking debate among investors. Bulls emphasize the robust performance of its high-margin inside sales, particularly pizza, and positive fiscal year guidance, while bears point to slowing growth in prepared food and flat fuel volumes, questioning its valuation.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as it begins early U.S. operations under a White House-backed eVTOL Integration Pilot Program and launches Uber Air in Dubai, marking significant progress toward commercial air taxi services. The community is actively discussing these milestones alongside recent positive earnings and ongoing comparisons with competitor Archer Aviation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies Financial Group Inc. Takes Position in Abivax SA Sponsored ADR $ABVX

Jefferies Financial Group Inc. bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought...

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the stock, Marketbeat.com...

Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 13.2% in February

Abivax SA Sponsored ADR (NASDAQ:ABVX - Get Free Report) was the target of a large drop in short interest in February. As of February 13th, there was short interest totaling 3,172,758 shares, a drop...

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

PHAR heads into Q4 results, with Ruconest and Joenja sales in focus, pipeline updates looming, and investors eyeing clarity on key regulatory setbacks.

Erste Asset Management GmbH Buys New Position in Abivax SA Sponsored ADR $ABVX

Erste Asset Management GmbH purchased a new position in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...

Envestnet Asset Management Inc. Acquires New Stake in Abivax SA Sponsored ADR $ABVX

Envestnet Asset Management Inc. bought a new stake in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities...

Optiver Holding B.V. Makes New Investment in Abivax SA Sponsored ADR $ABVX

Optiver Holding B.V. bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the...

Abivax's (ABVX) "Buy" Rating Reiterated at BTIG Research

BTIG Research reissued a "buy" rating and issued a $150.00 price objective on shares of Abivax in a research note on Wednesday...

Abivax (NASDAQ:ABVX) Shares Down 5.4% - Here's Why

Abivax (NASDAQ:ABVX) Shares Down 5.4% - Here's Why...

Patient Square Capital LP Purchases Shares of 151,833 Abivax SA Sponsored ADR $ABVX

Patient Square Capital LP purchased a new position in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Current Price	$109.61
Prev Close	$109.33
Open	$108.19
Dividend Yield	0.00%
50-Day Moving Average	$122.22
Beta	0.78
Avg. Volume	799,719.86
PE Ratio	-36.16

52-Week High	$148.83
52-Week Low	$4.77
Market Capitalization	$8.65B
EPS (Annual)	-$3.02
Price to Book	14.17
Revenue Per Employee	$0.00

ABVX
Abivax - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABVX News

ABVXAbivax - ADR